在ADA方法开发中减轻先前存在的免疫性.
Jihua Chen1, Henry Zhao1, Chris Gardner1
1Bioanalytical Development, Alexion Pharmaceuticals, AstraZeneca Rare Disease, New Haven, CT, USA.
Bioanalysis
|February 3, 2026
概括
在患者中存在的免疫反应性可能会挑战对生物疗法的抗药抗体 (ADA) 试验的开发. 一种经过修改的ADA试验有效地减轻了这种干扰,确保了可靠的免疫性评估.
科学领域:
- 生物制剂 生物制剂 生物制剂
- 免疫学 免疫学 免疫学
- 测试开发 测试开发
背景情况:
- 免疫性评估对于生物疗法至关重要.
- 预先存在的免疫反应性复杂化了抗药抗体 (ADA) 测试的开发和切割点的确定.
- 在ALXN-X计划中,约50%的样本显示出显著的先前反应性,具有挑战性的测试方法.
研究的目的:
- 描述对ALXN-X.的预先存在的反应性质.
- 开发一种经过修改的ADA试验,以减轻因先前存在的反应性而产生的干扰.
- 确保ALXN-X治疗药物的可靠免疫性评估.
主要方法:
- 竞争性抑制实验被用来绘制绑定站点的地图.
- 耗尽蛋白质A/G阿加洛斯的特征反应性.
- 一个经过修改的ADA试验使用了工程制造的药物分子.
主要成果:
- 预先存在的反应性针对ALXN-X.的C端保存框架序列.
- 这种反应性很可能是免疫球蛋白介导的.
- 修改后的ADA试验有效地减轻了干扰,同时保持了对ALXN-X特异性ADA的敏感性.
结论:
- 对ALXN-X的C-终端序列存在的免疫球蛋白中介反应性复杂化了ADA试验.
- 一种经过修改的ADA试验成功地减轻了这种干扰.
- 修改后的试验通过检测ALXN-X特异性ADA,支持可靠的免疫性评估.
相关概念视频
Development of Analytical Methods
2.2K
An analytical methodology can be divided into four sequential steps: technique, method, procedure, and protocol. A technique is a scientific principle that rationalizes a specific phenomenon through chemical measurements. Adapting a technique for analyzing a sample of interest is termed a method. The procedure outlines the directions for performing the analysis via an analytical method. The protocol is the detailed guidelines on the procedure, which should be strictly followed to obtain the...
2.2K
pre-mRNA Processing
57.5K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.5K
Pre-mRNA Processing: Modification of pre-mRNA Ends
14.9K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
14.9K
Chromatin Structure Regulates pre-mRNA Processing
8.2K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
8.2K
Pre-mRNA Processing: RNA Splicing
6.9K
6.9K
Tracheostomy Care I: Pre-procedural Steps
1.2K
A tracheostomy is a surgical technique that involves making an incision in the neck to provide access to the trachea. It is frequently used in medical conditions such as airway obstruction and prolonged mechanical ventilation. Effective nursing management is crucial for the long-term success of a tracheostomy.
Required Equipment
The equipment necessary for tracheostomy care includes:
Required Equipment
The equipment necessary for tracheostomy care includes:
1.2K


